Impact of the blood sampling site on time–concentration drug profiles following intravenous or buccal drug administration

Abstract

The aim of this study was to examine the effect of the sampling site on the drug concentration–time profile, following intravenous or buccal (often called ‘oral transmucosal’) drug administration. Buprenorphine (20 μg/kg) was administered IV or buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the W ilcoxon signed rank test, applying the B onferroni correction. Significance was set at P < 0.05. Following IV administration, no difference among the sampling sites was found. Following buccal administration, maximum concentration [jugular: 6.3 (2.9–9.8), carotid: 3.4 (1.9–4.9), medial saphenous: 2.5 (1.7–4.1) ng/mL], area under the curve [jugular: 395 (335–747), carotid: 278 (214–693), medial saphenous: 255 (188–608) ng·min/mL], and bioavailability [jugular: 47 (34–67), carotid: 32 (20–52), medial saphenous: 23 (16–55)%] were higher in the jugular vein than in the carotid artery and medial saphenous vein. Jugular venous blood sampling is not an acceptable substitute for arterial blood sampling following buccal drug administration.